Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Collection:
Health Policy and Services Research
Author(s):
Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author
Contributor(s):
Institute for Clinical and Economic Review, issuing body.
New England Comparative Effectiveness Public Advisory Council
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021
Language(s):
English
Format:
Text
Subject(s):
Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (various pagings))
Illustrations:
Illustrations
NLM Unique ID:
9918400686506676 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/9918400686506676